173 related articles for article (PubMed ID: 33586444)
41. Homologous polydopamine ameliorates haemolysis of melittin for enhancing its anticancer efficacy.
Zheng Y; Wei Q; Han X; Tao X; Cao T; Chen T; Cao P; Zhan Q
J Mater Chem B; 2024 Jun; 12(22):5431-5438. PubMed ID: 38726737
[TBL] [Abstract][Full Text] [Related]
42. The pH-controlled nanoparticles size of polydopamine for anti-cancer drug delivery.
Ho CC; Ding SJ
J Mater Sci Mater Med; 2013 Oct; 24(10):2381-90. PubMed ID: 23797829
[TBL] [Abstract][Full Text] [Related]
43. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
44. Responsive functionalized MoSe
Liu Y; Wei C; Lin A; Pan J; Chen X; Zhu X; Gong Y; Yuan G; Chen L; Liu J; Luo Z
Colloids Surf B Biointerfaces; 2020 May; 189():110820. PubMed ID: 32045843
[TBL] [Abstract][Full Text] [Related]
45. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W
Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071
[TBL] [Abstract][Full Text] [Related]
46. Core-shell Fe3O4 polydopamine nanoparticles serve multipurpose as drug carrier, catalyst support and carbon adsorbent.
Liu R; Guo Y; Odusote G; Qu F; Priestley RD
ACS Appl Mater Interfaces; 2013 Sep; 5(18):9167-71. PubMed ID: 24010676
[TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics and Tissue Distribution of Folate-Decorated Human Serum Albumin Loaded With Nano-Hydroxycamptothecin for Tumor Targeting.
Wang W; Liang H; Sun B; Xu J; Zeng Z; Zhao X; Li Q
J Pharm Sci; 2016 Jun; 105(6):1874-1880. PubMed ID: 27129905
[TBL] [Abstract][Full Text] [Related]
48. Novel Multifunctional Stimuli-Responsive Nanoparticles for Synergetic Chemo-Photothermal Therapy of Tumors.
Pu XQ; Ju XJ; Zhang L; Cai QW; Liu YQ; Peng HY; Xie R; Wang W; Liu Z; Chu LY
ACS Appl Mater Interfaces; 2021 Jun; 13(24):28802-28817. PubMed ID: 34109788
[TBL] [Abstract][Full Text] [Related]
49. pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma.
Wu M; Zhong C; Zhang Q; Wang L; Wang L; Liu Y; Zhang X; Zhao X
J Nanobiotechnology; 2021 Feb; 19(1):39. PubMed ID: 33549107
[TBL] [Abstract][Full Text] [Related]
50. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors.
Lian B; Wu M; Feng Z; Deng Y; Zhong C; Zhao X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):154-165. PubMed ID: 30686050
[TBL] [Abstract][Full Text] [Related]
51. Barbaloin loaded polydopamine-polylactide-TPGS (PLA-TPGS) nanoparticles against gastric cancer as a targeted drug delivery system: Studies in vitro and in vivo.
Wang YR; Yang SY; Chen GX; Wei P
Biochem Biophys Res Commun; 2018 Apr; 499(1):8-16. PubMed ID: 29534962
[TBL] [Abstract][Full Text] [Related]
52. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
53. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
54. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
55. Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia.
Li Z; Zhang Y; Zhu C; Guo T; Xia Q; Hou X; Liu W; Feng N
Int J Pharm; 2020 Aug; 586():119576. PubMed ID: 32603839
[TBL] [Abstract][Full Text] [Related]
56. Polydopamine-mediated bio-inspired synthesis of copper sulfide nanoparticles for T
Xiong Y; Sun F; Zhang Y; Yang Z; Liu P; Zou Y; Yu Y; Tong F; Yi C; Yang S; Xu Z
Colloids Surf B Biointerfaces; 2019 Jan; 173():607-615. PubMed ID: 30359959
[TBL] [Abstract][Full Text] [Related]
57. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery.
Xin Y; Liu T; Yang C
Int J Nanomedicine; 2016; 11():5807-5821. PubMed ID: 27853366
[TBL] [Abstract][Full Text] [Related]
58. Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.
Nie J; Cheng W; Peng Y; Liu G; Chen Y; Wang X; Liang C; Tao W; Wei Y; Zeng X; Mei L
Drug Deliv; 2017 Nov; 24(1):1124-1138. PubMed ID: 28789585
[TBL] [Abstract][Full Text] [Related]
59. Folic Acid Decorated Zeolitic Imidazolate Framework (ZIF-8) Loaded with Baicalin as a Nano-Drug Delivery System for Breast Cancer Therapy.
Mi X; Hu M; Dong M; Yang Z; Zhan X; Chang X; Lu J; Chen X
Int J Nanomedicine; 2021; 16():8337-8352. PubMed ID: 34992370
[TBL] [Abstract][Full Text] [Related]
60. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]